...
首页> 外文期刊>Medical principles and practice: international journal of the Kuwait University, Health Science Centre >Inhibition of Ras-GTPase improves diabetes-induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed.
【24h】

Inhibition of Ras-GTPase improves diabetes-induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed.

机译:Ras-GTPase的抑制作用改善了大鼠灌注的肠系膜血管床的糖尿病诱导的异常血管反应性。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: The signalling mechanisms involved in regulating altered vascular reactivity in diabetes are not fully understood. The aim of this study was to investigate the role of Ras-GTPase in the development of abnormal vascular reactivity in diabetes. MATERIALS AND METHODS: We investigated the ability of chronic administration of FPTIII (1.5 mg/kg), an inhibitor of Ras-GTPase, to modulate the altered vasoreactivity of the rat perfused mesenteric bed to common vasoconstrictors and vasodilators in streptozotocin (STZ)-induced diabetes. RESULTS: The vasoconstrictor responses induced by norepinephrine (NE) and endothelin-1 (ET-1) were significantly increased whereas vasodilator responses to carbachol, histamine and isoprenaline were significantly reduced in the perfused mesenteric bed of the STZ-diabetic rats. Inhibition of Ras-GTPase by chronic administration of FPTIII produced a significant normalization of the altered agonist-induced vasoconstrictor and vasodilator responses without affecting blood glucose levels. Inhibition of Ras-GTPase did not affect the agonist-induced vasoconstrictor and vasodilator responses in the control animals. CONCLUSION: These data suggest that signal transduction pathways activated by Ras-GTPase are involved in the development of diabetic vascular dysfunction. Potential strategies aimed at modifying actions of signal transduction pathways involving Ras-GTPase may therefore prove to be beneficial in treatment of vascular complications in diabetes.
机译:目的:尚未完全了解调节糖尿病血管反应性所涉及的信号传导机制。这项研究的目的是调查Ras-GTPase在糖尿病异常血管反应性发展中的作用。材料与方法:我们研究了长期施用Ras-GTPase抑制剂FPTIII(1.5 mg / kg)调节大鼠灌肠系膜床对链脲佐菌素(STZ)诱导的常见血管收缩剂和血管扩张剂改变的血管反应性的能力。糖尿病。结果:在STZ-糖尿病大鼠的灌流肠系膜床中,去甲肾上腺素(NE)和内皮素-1(ET-1)诱导的血管收缩反应显着增加,而对卡巴胆碱,组胺和异丙肾上腺素的血管舒张反应显着降低。长期给予FPTIII抑制Ras-GTPase可以使激动剂诱导的血管收缩剂和血管舒张剂反应发生明显的正常化,而不会影响血糖水平。抑制Ras-GTPase不会影响对照组动物激动剂诱导的血管收缩和血管舒张反应。结论:这些数据表明,Ras-GTPase激活的信号转导通路参与了糖尿病血管功能障碍的发展。因此,旨在改变涉及Ras-GTPase的信号转导途径的作用的潜在策略可能证明对治疗糖尿病的血管并发症有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号